期刊：Oxidative Medicine and Cellular Longevity
文獻題目：Anti-PD-L1 Antibody Enhances T Cell Immune Responses and Reduces Resistance of Breast Cancer Cells to Radiotherapy
作者：Guo Lei-Ming, Ding Gao-Feng, Xu Wen-Cai, Ge Hong, Jiang Yue, Lu Yu-Fei
DOI：10.1155/2022/5938688
引用產品： hematoxylin
影響因子：7.31
原文鏈接：https://www.hindawi.com/journals/omcl/2022/5938688
